Loading...
Loading...
ICU| Name | Value |
|---|---|
| Revenues | 0.0K |
| Cost of Revenue | 0.0K |
| Gross Profit | 0.0K |
| Operating Expense | 4,669.0K |
| Operating I/L | -4,669.0K |
| Other Income/Expense | 1,436.0K |
| Interest Income | 25.0K |
| Pretax | -3,233.0K |
| Income Tax Expense | 3.0K |
| Net Income/Loss | -3,236.0K |
SeaStar Medical Holding Corporation is a medical device company specializing in developing and commercializing extracorporeal therapies to treat hyperinflammation and cytokine storm in critically ill patients. The company's products target effector cells that drive systemic inflammation, causing tissue damage and secreting pro-inflammatory cytokines. SeaStar Medical is focused on developing products for pediatric and adult acute kidney injury on CRRT, cardiorenal syndrome in congestive heart failure with and without LVAD, myocardial stunning in end stage renal disease, and hepatorenal syndrome.
